Original Article | Published:

Pulmonary Pharmacology

5-Hydroxytryptamine-induced proliferation of pulmonary artery smooth muscle cells are extracellular signal-regulated kinase pathway dependent

Abstract

Aim:

To investigate the effect of 5-hydroxytryptamine transporter (5-HTT) inhibitor fluoxetine and antisense oligodeoxynucleotide (ODN) to extracelluar signalregulated kinases (ERKs) on pulmonary arterial smooth muscle cells (PASMCs) proliferation induced by 5-HT.

Methods:

Liposomal transfection was used to introduce ODNs to ERK1/2 into cultured rat PASMCs and the transfection efficiency was measured by observing the uptake of the fluorecein isothiocynate (FITC)-labeled antisense ODN in PASMCs. The effects of 5-HTT selective inhibitor fluoxetine and ODNs on the proliferation of PASMCs were evaluated by cell number counting and cell cycle analysis, and measured by microculture tetrazolium (MTT) assay and flow cytometry (FCM), respectively.

Results:

Liposomes mediated the transfection of ODNs into PASMCs with high efficiency. MTT assay showed fluoxetine (10 μmol/L, 1 μmol/L, and 100 nmol/L) concentration dependently inhibited the proliferation of PASMCs induced by 5-HT (1 μmol/L) in vitro. The proliferation rate of PASMCs by 5-HT was significantly inhibited by pretreatment with ERK1/2 antisense ODN (0.2 μmol/L) from 251%±18% to 86%±5% (P<0.01). Flow cytometric analysis of cell cycle distribution showed that the increase of 5-HT induced S phase fraction (SPF) and proliferation index (PI) were significantly inhibited by fluoxetine (1 μmol/L) or antisense ODN with SPF from 36%±4% to 26%±3% and 24%±4%, and PI from 34%±2% to 29%±2% and 24%±2%, respectively.

Conclusion:

5-HTT mediates the mitogenic effect of 5-HT on PASMCs and the proliferation of PASMCs induced by 5-HT is dependent on ERKs signal pathway.

References

  1. 1

    Fishman AP . Clinical classification of pulmonary hypertension. Clin Chest Med 2001; 22: 385–91.

  2. 2

    Jeffery TK, Morrell NW . Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Prog Cardiovasc Dis 2002; 45: 173–202.

  3. 3

    Eddahibi S, Morrell N, d'Ortho MP, Maeije R, Adnot S . Pathobiology of pulmonary arterial hypertension. Eur Respir J 2002; 20: 1559–72.

  4. 4

    Lee SL, Wang WW, Lanzillo JJ, Fanburg BL . Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth cells in culture. Am J Physiol 1994; 266: L46–52.

  5. 5

    Eddahibi S, Fabre V, Boni C, Martres MP, Raffestin B, Hamon M, et al. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res 1999; 84: 329–36.

  6. 6

    Robinson MJ, Cobb MH . Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997; 9: 180–6.

  7. 7

    Force T, Bonventre JV . Growth factors and mitogen-activated protein kinases. Hypertension 1998; 31: 152–61.

  8. 8

    Florian JA, Watts SW . Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction. J Pharmacol Exp Ther 1998; 284: 346–55.

  9. 9

    Watts SW, Yang P, Banes AK, Baez M . Activation of Erk mitogen-activated protein kinase proteins by vascular serotonin receptors. J Cardiovasc Pharmacol 2001; 38: 539–51.

  10. 10

    Hinton JM, Hill P, Jeremy J, Garland C . Signalling pathways activated by 5-HT1B/5-HT1D receptors in native smooth muscle and primary cultures of rabbit renal artery smooth muscle cells. J Vasc Res 2000; 37: 457–68.

  11. 11

    Rothman A, Kulik TJ, Taubman MB, Berk BC, Smith CW, Nadal-Ginard B . Development and characterization of a cloned rat pulmonary arterial smooth muscle cell line that maintains differentiated properties through multiple subcultures. Circulation 1992; 86: 1977–86.

  12. 12

    Huang SL, Ding B, Yu QS, Guo ZG . Effect of antisense mitogenactivated protein kinase oligonucleotides on rat vascular smooth muscle cell proliferation induced by EGR in vitro. Acta Pharmacol Sin 1998; 19: 489–93.

  13. 13

    MacLean MR, Herve P, Eddahibi S, Adnot S . 5-Hydrox-ytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Parmacol 2000; 131: 161–8.

  14. 14

    Ullmer C, Schmuck K, Kalkman HO, Lubbert H . Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett 1995; 370: 215–21.

  15. 15

    Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, et al. Antidepressant-and cocaine-sensitive human serotonin transporter: molecular cloning expression and chromosomal location. Proc Natl Acad Sci USA 1993; 90: 2542–6.

  16. 16

    Marcos E, Adnot S, Pham MH, Nosjean A, Raffestin B, Hamon M, et al. Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension. Am J Respir Crit Care Med 2003; 168: 487–93.

  17. 17

    Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 2001; 108: 1141–50.

  18. 18

    Marcos E, Adnot S, Pham MH, Nosjean A, Raffestin B, Hamon M, et al. Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension. Am J Respir Crit Care Med 2003; 168: 487–93.

  19. 19

    Eddahibi S, Hanoun N, Lanfumey L, Lesch KP, Raffestin B, Hamon M, et al. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest 2000; 105: 1555–62.

  20. 20

    Fisher M, Liu B, Glennon PE, Southgate KM, Sale EM, Sale GJ, et al. Downregulation of the ERK 1 and 2 mitogen activated protein kinases using antisense oligonucleotides inhibits proliferation of porcine vascular smooth muscle cells. Atherosclerosis 2001; 156: 289–95.

  21. 21

    Lee SL, Wang WW, Fanburg BL . Association of Tyr phosphorylation of GTPase-activating protein with mitogenic action of serotonin. Am J Physiol 1997; 272: C223–30.

  22. 22

    Lee SL, Wang WW, Finlay GA, Fanburg BL . Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion. Am J Physiol 1999; 277: L282–91.

  23. 23

    Lee SL, Simon AR, Wang WW, Fanburg BL . H2O2 signals 5-HT-induced ERK MAP kinase activation and mitogenesis of smooth muscle cells. Am J Physiol 2001; 281: L646–52.

Download references

Author information

Correspondence to Huai-liang Wang.

Additional information

Project supported in part by National Natural Science Foundation of China (No 0271510) and the Science and Technology Committee of China (No 9690105274).

Rights and permissions

Reprints and Permissions

About this article

Keywords

  • antisense oligodeoxyribonucleotides
  • serotonin
  • membrane transport proteins
  • pulmonary hypertension
  • vascular smooth muscle
  • fluoxetine
  • mitogen-activated protein kinases

Further reading